VERNON HILLS, Ill.--(BUSINESS WIRE)--Applied NeuroSolutions, Inc. (OTC BB:APNS)(www.appliedneurosolutions.com) a Company focused on the development of an integrated product portfolio for the treatment and diagnosis of Alzheimer’s disease (AD), today announced it’s long-standing founding scientist, Dr. Peter Davies, a world renowned expert on AD research, was interviewed in a feature article entitled “Taking On Alzheimer’s” in the New York Times on June 10, 2007, indicating his novel approach to AD therapeutics is being developed in a collaboration between APNS and Eli Lilly and Company (NYSE: LLY).
